Multiple sclerosis (MS) is a debilitating neuroimmunological and neurodegenerative disease (MS [MIM 126200]) and is estimated to affect 400 000 individuals in the United States alone. Numerous ...
The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...
Multiple sclerosis (MS [MIM 126200]) is a neurodegenerative autoimmune disease characterized by demyelination within the central nervous system (CNS). Demyelination and the resulting formation of scar ...
Sanofi provides update on tolebrutinib in primary progressive multiple sclerosisPERSEUS phase 3 study in primary progressive multiple sclerosis ...
Learn 10 key facts about multiple sclerosis, including symptoms, treatments, diagnosis, and ways to manage the condition and live well.
The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...
Multiple sclerosis (MS) is a condition that affects your brain and spinal cord. It damages the myelin sheath, the tissue that surrounds and protects your nerve cells. This damage blocks or slows down ...
8don MSN
Using over-the-counter antioxidant to treat progressive multiple sclerosis shows mixed results
The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...
People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback